These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32735534)

  • 21. Onychomycosis: An Updated Review.
    Leung AKC; Lam JM; Leong KF; Hon KL; Barankin B; Leung AAM; Wong AHC
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(1):32-45. PubMed ID: 31738146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.
    De Doncker P; Decroix J; Piérard GE; Roelant D; Woestenborghs R; Jacqmin P; Odds F; Heremans A; Dockx P; Roseeuw D
    Arch Dermatol; 1996 Jan; 132(1):34-41. PubMed ID: 8546481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Onchomycosis: an overview.
    Elewski BE; Rich P; Tosti A; Pariser DM; Scher R; Daniel RC; Gupta AK
    J Drugs Dermatol; 2013 Jul; 12(7):s96-103. PubMed ID: 23884508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on current approaches to diagnosis and treatment of onychomycosis.
    Gupta AK; Mays RR; Versteeg SG; Shear NH; Piguet V
    Expert Rev Anti Infect Ther; 2018 Dec; 16(12):929-938. PubMed ID: 30411650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.
    Baswan S; Kasting GB; Li SK; Wickett R; Adams B; Eurich S; Schamper R
    Mycoses; 2017 May; 60(5):284-295. PubMed ID: 28098391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onychomycosis: burden of disease and the role of topical antifungal treatment.
    Daniel RC
    J Drugs Dermatol; 2013 Nov; 12(11):1263-6. PubMed ID: 24196334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into drug delivery across the nail plate barrier.
    Saner MV; Kulkarni AD; Pardeshi CV
    J Drug Target; 2014 Nov; 22(9):769-89. PubMed ID: 24964054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Onychomycosis : a crown jewel of dermatology].
    Tietz HJ; Nenoff P
    Hautarzt; 2012 Nov; 63(11):842-7. PubMed ID: 23064669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of Naftifine Application for Transungual Delivery.
    Šveikauskaitė I; Briedis V
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32635240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.
    Bristow I; Baran R; Score M
    J Drugs Dermatol; 2016 Aug; 15(8):974-8. PubMed ID: 27537998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging therapeutic agents for onychomycosis.
    Piérard GE; Arrese JE; Quatresooz P; Piérard-Franchimont C
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):345-53. PubMed ID: 17874965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK; Fleckman P; Baran R
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fungal nail infections (onychomycosis): a never-ending story?
    Ghannoum M; Isham N
    PLoS Pathog; 2014 Jun; 10(6):e1004105. PubMed ID: 24901242
    [No Abstract]   [Full Text] [Related]  

  • 36. Preparation and
    Lee BC; Pangeni R; Na J; Koo KT; Park JW
    Drug Deliv; 2019 Dec; 26(1):1167-1177. PubMed ID: 31738083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F; Hui X; Selner M; Rosenthal B; Maibach H
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
    Traynor MJ; Turner RB; Evans CR; Khengar RH; Jones SA; Brown MB
    J Pharm Pharmacol; 2010 Jun; 62(6):730-7. PubMed ID: 20636860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing the nail permeability of topically applied drugs.
    Murdan S
    Expert Opin Drug Deliv; 2008 Nov; 5(11):1267-82. PubMed ID: 18976136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strategies for the enhancement of nail plate permeation of drugs to treat onychomycosis.
    Gupta AK; Polla Ravi S; Choi SY; Konda A; Cooper EA
    J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):243-255. PubMed ID: 36196052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.